Last year marked the first time that erythropoietins were not the top-selling biotech drugs. Stacy Lawrence looks at the biopharmaceuticals that have usurped them.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
Scientific Reports Open Access 17 July 2017
-
Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel
Scientific Reports Open Access 01 July 2014
-
A dynamic method for the investigation of induced state metabolic capacities as a function of temperature
Microbial Cell Factories Open Access 15 October 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Supplementary information
Supplementary Table 1
Major biologics. (DOC 34 kb)
Related links
Related links
Related links in Nature Research
2004 approvals: the demise of the blockbuster?
Amgen's TPO mimic faces stiff competition
Biotech drug market steadily expands
Web links
Rights and permissions
About this article
Cite this article
Lawrence, S. Billion dollar babies—biotech drugs as blockbusters. Nat Biotechnol 25, 380–382 (2007). https://doi.org/10.1038/nbt0407-380
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0407-380
This article is cited by
-
Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery
Nature Reviews Chemistry (2020)
-
A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
Scientific Reports (2017)
-
Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel
Scientific Reports (2014)
-
Glycoengineering in plants for the development of N-glycan structures compatible with biopharmaceuticals
Plant Biotechnology Reports (2014)
-
A dynamic method for the investigation of induced state metabolic capacities as a function of temperature
Microbial Cell Factories (2013)
